Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Non-Current Deffered Revenue: 2011-2017

Historic Non-Current Deffered Revenue for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Jun 2017 value amounting to $51,000.

  • EyePoint Pharmaceuticals' Non-Current Deffered Revenue fell 26.32% to $42,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $42,000, marking a year-over-year decrease of 26.32%. This contributed to the annual value of $51,000 for FY2017, which is 99.09% down from last year.
  • According to the latest figures from FY2017, EyePoint Pharmaceuticals' Non-Current Deffered Revenue is $51,000, which was down 99.09% from $5.6 million recorded in FY2016.
  • Over the past 5 years, EyePoint Pharmaceuticals' Non-Current Deffered Revenue peaked at $5.6 million during FY2015, and registered a low of $51,000 during FY2017.
  • Its 3-year average for Non-Current Deffered Revenue is $3.7 million, with a median of $5.6 million in 2016.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Non-Current Deffered Revenue soared by 38.67% in 2013 and then slumped by 99.09% in 2017.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Non-Current Deffered Revenue stood at $5.2 million in 2013, then increased by 6.44% to $5.6 million in 2014, then grew by 0.21% to $5.6 million in 2015, then dropped by 0.20% to $5.6 million in 2016, then crashed by 99.09% to $51,000 in 2017.